OVERVIEW

Latest Advances in Low-Grade UTUC Therapies is organized by Prime Education, LLC and will be held from Aug 30, 2024 - Aug 29, 2025.

Release Date: August 30, 2024
Expiration Date: August 29, 2025

Description:
Discover the latest guidelines for diagnosing, evaluating, and risk stratifying in upper tract urothelial carcinoma (UTUC) patients in our dynamic, expert-led, on-demand video.
Learn how to apply current evidence to select the most suitable therapies and sequences for patients, considering safety, efficacy, and administration routes. Delve into the mechanism behind novel chemoablation strategies through a dynamic whiteboard video explanation, enhancing your understanding of its action and potential impact on treatment outcomes.

Learning Objectives:

  • Assess current guidelines for diagnosis, evaluation, and risk stratification in patients with UTUC
  • Apply current evidence to guide appropriate patient selection and novel therapy selection and sequencing
  • Differentiate available therapies for UTUC based on safety and efficacy data, routes of administration, and indications

Additional details will be posted as soon as information is available.

Credits

Accreditation: 
Joint Accreditation Statement
In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Credit Designation Statement
PRIME® designates this Enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistant Accreditation Statement
PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioner Accreditation Statement
PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 0.5 contact hour (which includes 0.3 hour of pharmacology).

Pharmacist Accreditation Statement
This Knowledge-based activity has been approved for 0.5 contact hour (0 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-24-202-H01-P . Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity by providing your NABP ID & DOB, which must be submitted within 60 days of completion. Pharmacists with questions can contact NABP customer service (help@nabp.pharmacy).

Nurse Accreditation Statement
PRIME® designates this activity for 0.5 contact hour.

  • 0.5 AMA PRA Category 1 Credit™
  • 1 Contact Hours
  • 0.5 CME
  • TARGET AUDIENCE

    PhysicianNursingPharmacistOncologistsUrologistsNursesNurse PractitionersMedical Oncologists

    SPECIALITIES

    UrologyOncology

    RELATED ONLINE COURSES

    3 Hours
    ...
    More actions

    Webcast

    Pediatrics
    28 AMA PRA Category 1 Credits™
    More actions
    US$910
    By MasterHealthPro (MHP)

    Webcast

    Psychiatry
    72 CPD Hours
    More actions
    IN₹32,499